Clinigen Group plc announces the appointment of Elmar Schnee as independent Non-Executive Director and Chairman designate and Ian Johnson as a new independent Non-Executive Director and Senior Independent Director. Both appointments are effective from 03 August 2021. As announced in the Company's trading update on 13 July 2021, Peter Allen, independent Non-Executive Chairman, will not stand for re-election to the Board at the Annual General Meeting (AGM) in November 2021. Peter Allen has served as Chairman since the Group's IPO in September 2012. It is expected that Elmar Schnee will assume the role of Chairman following the AGM in November 2021. Ian Nicholson will also step down at the November AGM. Ian joined the Board in September 2012 and has served as a member of the Nomination and Audit and Risk Committees and chaired the Remuneration Committee. Anne Hyland will step down from her position as Senior Independent Director, but will remain Chair of the Audit and Risk Committee and an independent Non-Executive Director.